Aim ImmunoTech
(NYSEMKT) AIM
Aim ImmunoTech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$88.00K
Net Income (TTM)
$13.96M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AIM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aim ImmunoTech
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Thomas Kenwood Equels
Website
www.aimimmuno.comHeadquarters
Ocala, FL 34473, US
AIM Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
-127%
Net Income Margin
-159%
Return on Equity
2%
Return on Capital
25%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$250.00K
Operating Income
$10.53M
EBITDA
$10.32M
Operating Cash Flow
$10.96M
Capital Expenditure
$0.00
Free Cash Flow
$10.96M
Cash & ST Invst.
$993.00K
Total Debt
$4.90M
Aim ImmunoTech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.00K
-53.3%
Gross Profit
$62.00K
-164.6%
Gross Margin
-2.95%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
21
N/A
Net Income
$4.17M
+30.0%
EBITDA
$2.47M
+57.2%
Quarterly Fundamentals
Net Cash
$3.90M
-476.7%
Accounts Receivable
$7.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.10M
+177.7%
Short Term Debt
$3.80M
+49.2%
Return on Assets
-2.41%
N/A
Return on Invested Capital
25.21%
N/A
Free Cash Flow
$1.99M
+51.3%
Operating Cash Flow
$1.99M
+49.8%